168 related articles for article (PubMed ID: 6111201)
1. Cell-mediated immunity to varicella-zoster virus as assessed by the migration inhibition test.
Trlifajová J; Svejcar J; Svandová E; Ryba M; Pekárek J
Acta Virol; 1980 Dec; 24(6):406-14. PubMed ID: 6111201
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility to varicella-zoster virus in Thai children and young adults.
Kositanont U; Wasi C; Oonsombat P; Suvatte V; Thongcharoen P
Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):414-20. PubMed ID: 3006266
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunoassay for antibodies in varicella-zoster virus serology.
Trlifajova J; Pokorný J; Nĕmecek V; Ryba M
J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):332-9. PubMed ID: 231068
[TBL] [Abstract][Full Text] [Related]
4. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.
Wrensch M; Weinberg A; Wiencke J; Miike R; Sison J; Wiemels J; Barger G; DeLorenze G; Aldape K; Kelsey K
Am J Epidemiol; 2005 May; 161(10):929-38. PubMed ID: 15870157
[TBL] [Abstract][Full Text] [Related]
5. The effect of vaccination on the epidemiology of varicella zoster virus.
Edmunds WJ; Brisson M
J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
[TBL] [Abstract][Full Text] [Related]
6. Humoral and cellular immunity to varicella-zoster virus: an overview.
Arvin AM
J Infect Dis; 2008 Mar; 197 Suppl 2():S58-60. PubMed ID: 18419410
[No Abstract] [Full Text] [Related]
7. Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era.
Perella D; Fiks AG; Jumaan A; Robinson D; Gargiullo P; Pletcher J; Forke CM; Schmid DS; Renwick M; Mankodi F; Watson B; Spain CV
Pediatrics; 2009 May; 123(5):e820-8. PubMed ID: 19403475
[TBL] [Abstract][Full Text] [Related]
8. Studies on neutralization of varicella-zoster virus and serological follow-up of cases of varicella and zoster.
Asano Y; Takahashi M
Biken J; 1978 Mar; 21(1):15-23. PubMed ID: 208504
[No Abstract] [Full Text] [Related]
9. Increased migration inhibition factor production by leukocytes of patients with herpes zoster given the leukocyte ultrafiltrate.
Lackovicová M; Zachar V; Necas S; Mayer V
Acta Virol; 1989 Sep; 33(5):428-34. PubMed ID: 2576583
[TBL] [Abstract][Full Text] [Related]
10. IgM to varicella-zoster virus: demonstration in patients with and without clinical zoster.
Gershon AA; Steinberg SP; Borkowsky W; Lennette D; Lennette E
Pediatr Infect Dis; 1982; 1(3):164-7. PubMed ID: 6292875
[TBL] [Abstract][Full Text] [Related]
11. Immune evasion as a pathogenic mechanism of varicella zoster virus.
Abendroth A; Arvin AM
Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797
[TBL] [Abstract][Full Text] [Related]
12. [An immunological study of herpes zoster patients III--specific immunity (author's transl)].
Vacek Z; Trlifajová J; Doutlík S; Vasícková M; Ryba M
Cesk Dermatol; 1981 Feb; 56(1):11-6. PubMed ID: 6260390
[No Abstract] [Full Text] [Related]
13. Complement fixing antibody to varicella-zoster virus in different age groups and after zoster.
Moschen ME; Peserico A; Trivello R
Boll Ist Sieroter Milan; 1977 Mar; 56(1):70-3. PubMed ID: 193530
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
[TBL] [Abstract][Full Text] [Related]
15. Varicella morbidity in Czechoslovakia.
Trlifajová J; Svandová E; Havrlantová M; Galetková A
J Hyg Epidemiol Microbiol Immunol; 1980; 24(2):192-9. PubMed ID: 6251130
[TBL] [Abstract][Full Text] [Related]
16. [Reactivation of herpes zoster infection by varicella-zoster virus].
Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
[TBL] [Abstract][Full Text] [Related]
17. Immune responses to varicella-zoster in the aged.
Burke BL; Steele RW; Beard OW; Wood JS; Cain TD; Marmer DJ
Arch Intern Med; 1982 Feb; 142(2):291-3. PubMed ID: 6277260
[TBL] [Abstract][Full Text] [Related]
18. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
[TBL] [Abstract][Full Text] [Related]
19. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
[TBL] [Abstract][Full Text] [Related]
20. Indirect haemagglutination reaction with varicella-zoster virus antigen.
Trlifajová J; Pokorný J; Ryba M; Strízová V
J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):26-36. PubMed ID: 4350836
[No Abstract] [Full Text] [Related]
[Next] [New Search]
